The price of Jaguar Health Inc (NASDAQ: JAGX) closed at $0.18 in the last session, up 50.08% from day before closing price of $0.12. On the day, 604717087 shares were traded.
Ratios:
We take a closer look at JAGX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.34 and its Current Ratio is at 2.00. In the meantime, Its Debt-to-Equity ratio is 7.48 whereas as Long-Term Debt/Eq ratio is at 6.43.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 07, 2021, initiated with a Overweight rating and assigned the stock a target price of $5.
On July 11, 2017, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $2.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.81 while its Price-to-Book (P/B) ratio in mrq is 2.63.
Stock Price History:
Over the past 52 weeks, JAGX has reached a high of $1.22, while it has fallen to a 52-week low of $0.05.
Shares Statistics:
A total of 208.77M shares are outstanding, with a floating share count of 196.63M. Insiders hold about 5.81% of the company’s shares, while institutions hold 0.59% stake in the company.
Earnings Estimates
The company has — analysts who recommend its stock at the moment. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$9. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with — analysts recommending between $0 and $0.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $2.3M. It ranges from a high estimate of $2.61M to a low estimate of $2.61M. As of the current estimate, Jaguar Health Inc’s year-ago sales were $3.26M, an estimated decrease of -29.40% from the year-ago figure.
A total of 1 analysts have provided revenue estimates for JAGX’s current fiscal year. The highest revenue estimate was $9.32M, while the lowest revenue estimate was $9.32M, resulting in an average revenue estimate of $9.76M. In the same quarter a year ago, actual revenue was $11.96M, down -18.40% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $13.81M in the next fiscal year. The high estimate is $13.81M and the low estimate is $13.81M. The average revenue growth estimate for next year is up 41.50% from the average revenue estimate for this year.
